Lifetime and past-month substance use and injection among street-based female sex workers in Iran.
Drug use
Female sex workers
Harm reduction
Injection drug use
Iran
Journal
Harm reduction journal
ISSN: 1477-7517
Titre abrégé: Harm Reduct J
Pays: England
ID NLM: 101153624
Informations de publication
Date de publication:
16 03 2021
16 03 2021
Historique:
received:
05
02
2020
accepted:
26
02
2021
entrez:
17
3
2021
pubmed:
18
3
2021
medline:
26
11
2021
Statut:
epublish
Résumé
Street-based female sex workers (FSWs) are highly at risk of HIV and other harms associated with sex work. We assessed the prevalence of non-injection and injection drug use and their associated factors among street-based FSWs in Iran. We recruited 898 FSWs from 414 venues across 19 major cities in Iran between October 2016 and March 2017. Correlates of lifetime and past-month non-injection and injection drug use were assessed through multivariable logistic regression models. Adjusted odds ratios (AOR) and 95% confidence intervals (CI) were reported. Lifetime and past-month non-injection drug use were reported by 60.3% (95% CI 51, 84) and 47.2% (95% CI 38, 67) of FSWs, respectively. The prevalence of lifetime and past-month injection drug use were 8.6% (95% CI 6.9, 10.7) and 3.7% (95% CI 2.6, 5.2), respectively. Recent non-injection drug use was associated with divorced marital status (AOR 2.00, 95% CI 1.07, 3.74), temporary marriage (AOR 4.31 [1.79, 10.40]), had > 30 clients per month (AOR 2.76 [1.29, 5.90]), ever alcohol use (AOR 3.03 [1.92, 6.79]), and history of incarceration (AOR 7.65 [3.89, 15.30]). Similarly, lifetime injection drug use was associated with ever alcohol use (AOR 2.74 [1.20-6.20]), ever incarceration (AOR 5.06 [2.48-10.28]), and ever group sex (AOR 2.44 [1.21-4.92]). Non-injection and injection drug use are prevalent among street-based FSWs in Iran. Further prevention programs are needed to address and reduce harms associated with drug use among this vulnerable population in Iran.
Sections du résumé
BACKGROUND
Street-based female sex workers (FSWs) are highly at risk of HIV and other harms associated with sex work. We assessed the prevalence of non-injection and injection drug use and their associated factors among street-based FSWs in Iran.
METHODS
We recruited 898 FSWs from 414 venues across 19 major cities in Iran between October 2016 and March 2017. Correlates of lifetime and past-month non-injection and injection drug use were assessed through multivariable logistic regression models. Adjusted odds ratios (AOR) and 95% confidence intervals (CI) were reported.
RESULTS
Lifetime and past-month non-injection drug use were reported by 60.3% (95% CI 51, 84) and 47.2% (95% CI 38, 67) of FSWs, respectively. The prevalence of lifetime and past-month injection drug use were 8.6% (95% CI 6.9, 10.7) and 3.7% (95% CI 2.6, 5.2), respectively. Recent non-injection drug use was associated with divorced marital status (AOR 2.00, 95% CI 1.07, 3.74), temporary marriage (AOR 4.31 [1.79, 10.40]), had > 30 clients per month (AOR 2.76 [1.29, 5.90]), ever alcohol use (AOR 3.03 [1.92, 6.79]), and history of incarceration (AOR 7.65 [3.89, 15.30]). Similarly, lifetime injection drug use was associated with ever alcohol use (AOR 2.74 [1.20-6.20]), ever incarceration (AOR 5.06 [2.48-10.28]), and ever group sex (AOR 2.44 [1.21-4.92]).
CONCLUSIONS
Non-injection and injection drug use are prevalent among street-based FSWs in Iran. Further prevention programs are needed to address and reduce harms associated with drug use among this vulnerable population in Iran.
Identifiants
pubmed: 33726756
doi: 10.1186/s12954-021-00477-5
pii: 10.1186/s12954-021-00477-5
pmc: PMC7962286
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
33Subventions
Organisme : NIMH NIH HHS
ID : R25 MH123256
Pays : United States
Organisme : NIMH NIH HHS
ID : R25 MH064712
Pays : United States
Références
Drug Alcohol Depend. 2020 Jul 1;212:108039
pubmed: 32428789
Ann Epidemiol. 2019 Jul;35:29-34
pubmed: 31171443
Nepal J Epidemiol. 2016 Dec 31;6(4):620-630
pubmed: 28804674
HIV AIDS (Auckl). 2017 Jan 27;9:9-18
pubmed: 28184170
J Int Assoc Physicians AIDS Care (Chic). 2011 Sep-Oct;10(5):306-15
pubmed: 21368008
Eur J Contracept Reprod Health Care. 2020 Dec;25(6):434-438
pubmed: 32938240
Sex Transm Infect. 2020 Feb;96(1):68-75
pubmed: 31836679
Drug Alcohol Depend. 2018 Apr 1;185:260-265
pubmed: 29477085
Sex Transm Infect. 2013 Nov;89 Suppl 3:iii37-40
pubmed: 24191292
J Opioid Manag. 2006 Sep-Oct;2(5):283-9
pubmed: 17319260
Cult Health Sex. 2016;18(1):58-70
pubmed: 26317368
Subst Abuse Treat Prev Policy. 2009 May 27;4:11
pubmed: 19473505
Arch Sex Behav. 2020 Aug;49(6):1923-1937
pubmed: 31701288
Drug Alcohol Depend. 2021 Feb 26;221:108655
pubmed: 33689969
Psychol Health Med. 2010 Mar;15(2):172-87
pubmed: 20391235
Int J STD AIDS. 2014 Feb;25(2):155-61
pubmed: 23970644
Addict Behav. 2019 Mar;90:40-47
pubmed: 30355536
Public Health Rep. 2010 Jul-Aug;125 Suppl 4:81-9
pubmed: 20629253
J Acquir Immune Defic Syndr. 2017 May 1;75(1):9-17
pubmed: 28169873
AIDS Care. 2011 May;23(5):612-8
pubmed: 21390890
PLoS One. 2017 Aug 10;12(8):e0182755
pubmed: 28796847
Lancet. 2015 Jan 17;385(9964):287-301
pubmed: 25059950
Lancet Infect Dis. 2012 Jul;12(7):538-49
pubmed: 22424777
AIDS Care. 2015;27(3):293-300
pubmed: 25407357
Iran J Psychiatry Behav Sci. 2015 Jun;9(2):e1047
pubmed: 26288640
Int J Drug Policy. 2017 Jun;44:86-91
pubmed: 28478309
Int J Drug Policy. 2011 Jan;22(1):1-8
pubmed: 20800465
Subst Use Misuse. 2008 Jul;43(8-9):1202-17
pubmed: 18649239
Int J Drug Policy. 2016 Apr;30:124-31
pubmed: 26987607
Sex Health. 2015 Nov;12(6):560-2
pubmed: 26342286
Lancet. 2015 Jan 3;385(9962):55-71
pubmed: 25059947